Page last updated: 2024-12-07

rugulovasine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

rugulovasine A: from P. concavo-rugulosum Abe, P. islandicum, P. rubrum & P. biforme; RN given refers to (cis-(+-))-isomer; see also rugulovasine B, (trans-(+-))-isomer: 26909-34-2; structure in Merck Index, 9th ed, #8053 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID115153
MeSH IDM0088413

Synonyms (12)

Synonym
26909-33-1
unii-90dee096c5
90dee096c5 ,
spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, (2'r,4s)-rel-
spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, cis-(+-)-
rugulovasine a
spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, cis-(+/-)-
spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, cis-
rugulovasine a [mi]
piro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, (2'r,4s)-rel-
Q27271312
DTXSID20949700
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]